Skip to main content
. 2012 Mar 1;8:95–103. doi: 10.2147/TCRM.S23277

Table 1.

Examples of strong cytochrome P450 3A4 inhibitors with potential influence on the pharmacokinetics of coadministered ruxolitinib71,72

Drug
Ketoconazolea
Itraconazolea
Posaconazole
Voriconazole
Clarithromycin
Telithromycin
Atazanavir
Indinavir
Nelfinavir
Ritonavir
Saquinavir
Nefazodone

Note:

a

Observed interaction.70